Influenza News and Research

Latest Influenza News and Research

Aerosol-based study of COVID-19 risk indoors, and the impact of preventive measures

A recent study describes the estimated risk of COVID-19 transmission via aerosols in many different situations, as well as the expected reduction in risk associated with the use of various preventive measures.

24 Sep 2020

Elegant, efficient way to find recombinant SARS-CoV-2 viruses from >85,000 genomes

The low divergence of near-identical genomes that are sequenced in short periods presents a statistical challenge that is not addressed by methods available currently. In a recent bioRxiv** paper, Ales Varabyou et al. from John Hopkins University present an efficient method designed to detect recombination and reassortment events between clades of viral genomes – a new algorithm called ‘Bolotie’.

23 Sep 2020

New T-cell-based vaccine strategy provides broader protection against seasonal influenza

As Americans begin pulling up their sleeves for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternative vaccine approach that provides broader protection against seasonal influenza.

23 Sep 2020

Infants born to women with COVID-19 show few adverse outcomes

Infants born to women with COVID-19 showed few adverse outcomes, according to the first report in the country of infant outcomes through eight weeks of age.

23 Sep 2020

Common genetic variants may influence susceptibility to COVID-19

Researchers in the United States and Japan have conducted a study suggesting that a commonly occurring genetic variant influences susceptibility to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).

23 Sep 2020

Research explains why flu is dangerous for pregnant women

A team of researchers at the Royal Melbourne Institute of Technology (RMIT) University explains why flu can lead to potentially fatal complications during pregnancy, suggesting that the virus does not only stay in the respiratory tract but spreads throughout the body.

22 Sep 2020

Parkinson's disease diagnosed after SARS-CoV-2

As the COVID-19 pandemic continues to spread, new and unusual chronic sequelae of the disease are cropping up in many medical practices. Now, a new case paper published in The Lancet in September 2020 describes a case of new-onset Parkinson's disease following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

22 Sep 2020

Researchers examine the impact of human movement on disease spread

Due to continual improvements in transportation technology, people travel more extensively than ever before. Although this strengthened connection between faraway countries comes with many benefits, it also poses a serious threat to disease control and prevention.

22 Sep 2020

Respiratory specimens testing positive for SARS-CoV-2 decrease in the U.S., CDC report

In the report, published on Sept. 18, the CDC shows that indicators tracking COVID-19 activity continued to decline or remain stable. Still, two regions say a slight increase in the percentage of specimens testing positive for SARS-CoV-2. Meanwhile, four regions reported a slight increase in the percent of outpatient or emergency department visits for influenza-like illness (ILI).

22 Sep 2020

COVID-19 mitigation efforts significantly decrease influenza activity

The mitigation strategies implemented to curb the spread of COVID-19 appears to reduce the transmission of influenza in the United States, Australia, Chile, and South Africa. These strategies may augment influenza vaccines, especially for high-risk populations during the seasonal influenza transmission.

21 Sep 2020

Flu vaccine does not increase a person's COVID-19 risk, finds study

A new Cleveland Clinic study has found that receiving the influenza vaccine does not increase a person's risk for contracting COVID-19 or worsen associated morbidity or mortality.

21 Sep 2020

CDC updates coronavirus guidelines to recognize airborne spread

Early on in the pandemic, it was thought that the virus was only spread via respiratory droplets. However, scientific research soon showed it also to be an airborne virus. Now, the U.S. Centers for Disease Control and Prevention (CDC) has updated its guideline, acknowledging that the virus can hang in the air, fueling its spread.

21 Sep 2020

COVAM assay may help select convalescent plasma units for treatment of acute COVID-19

A recent study published on the preprint server bioRxiv* seeks to establish the pattern of antibody reactivity in COVID-19 convalescent plasma (CCP), which is widely being used as a therapy for seriously ill COVID-19 patients.

21 Sep 2020

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

A recent study published on the preprint server bioRxiv* in September 2020 shows the value of drug combinations to enhance the therapeutic and preventive efficacy of such repositioned drugs in standard antiviral therapy.

20 Sep 2020

Researchers try and pop SARS-CoV-2 with an AFM tip - virion surprisingly resilient

Researchers at Semmelweis University and the National Public Health Center in Hungary have conducted an imaging study showing that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for coronavirus disease 2019 (COVID-19), is a highly dynamic and resilient virus

20 Sep 2020

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

A new study published on the preprint server bioRxiv* in September 2020 reports on a Moloney murine leukemia virus (MLV) platform that produces VLPs expressing the important spike antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 Sep 2020

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

A recent study by researchers at the University of North Carolina at Chapel Hill and The Rockefeller University and published on the preprint server bioRxiv in September 2020 shows that a combination of neutralizing antibodies with intact Fc effector function can effectively reduce the viral load and prevent infection.

17 Sep 2020

Azelastine antihistamine inhibits SARS-CoV-2 infection in nasal tissue in vitro

In a study published on the bioRxiv preprint server, researchers from the University of Pécs, University of Vienna, and CEBINA GmbH, Vienna, show the ability of the antihistamine azelastine to inhibit SARS-CoV-2 infection in human nasal tissue in vitro.

16 Sep 2020

SARS-CoV-2 with D614G mutation is prevalent in central India

A team of scientists at the Defence Research and Development Establishment, India, reveals that there are multiple viral introduction events in central India, and SARS-CoV-2 with D614G mutation is the prevalently circulating strain.

16 Sep 2020

Tough to tell COVID from smoke inhalation symptoms — and flu season’s coming

The patients walk into Dr. Melissa Marshall's community clinics in Northern California with the telltale symptoms. They're having trouble breathing. It may even hurt to inhale. They've got a cough, and the sore throat is definitely there.

16 Sep 2020

Influenza News and Research

Latest Influenza News and Research

Aerosol-based study of COVID-19 risk indoors, and the impact of preventive measures

Elegant, efficient way to find recombinant SARS-CoV-2 viruses from >85,000 genomes

New T-cell-based vaccine strategy provides broader protection against seasonal influenza

Infants born to women with COVID-19 show few adverse outcomes

Common genetic variants may influence susceptibility to COVID-19

Research explains why flu is dangerous for pregnant women

Parkinson's disease diagnosed after SARS-CoV-2

Researchers examine the impact of human movement on disease spread

Respiratory specimens testing positive for SARS-CoV-2 decrease in the U.S., CDC report

COVID-19 mitigation efforts significantly decrease influenza activity

Flu vaccine does not increase a person's COVID-19 risk, finds study

CDC updates coronavirus guidelines to recognize airborne spread

COVAM assay may help select convalescent plasma units for treatment of acute COVID-19

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

Researchers try and pop SARS-CoV-2 with an AFM tip - virion surprisingly resilient

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

Azelastine antihistamine inhibits SARS-CoV-2 infection in nasal tissue in vitro

SARS-CoV-2 with D614G mutation is prevalent in central India

Tough to tell COVID from smoke inhalation symptoms — and flu season’s coming

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Influenza News and Research

Latest Influenza News and Research

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in